Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients
Hepatocellular carcinoma is the fifth most common malignant neoplasm worldwide. Most patients are not candidates to surgical treatment. The prognosis of this neoplasm is poor, with an overall survival rate of 8 weeks in unresectable tumors. Estrogen receptors have been found in up to 33% of this tum...
Main Authors: | Jorge García-Leiva, Armando Gamboa-Domínguez, Tania Ceron-Lizarraga, Daniela Morales-Espinosa, Judith Meza-Junco, Oscar Arrieta |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-10-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119319854 |
Similar Items
-
Tamoxifen non-estrogen receptor mediated molecular targets
by: Tatiana Bogush, et al.
Published: (2012-10-01) -
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
by: Andrea Miró-Canturri, et al.
Published: (2021-03-01) -
Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice
by: L.A.S. Silva, et al.
Published: (2017-11-01) -
Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
by: Chun-E Ren, et al.
Published: (2015-03-01) -
Tamoxifen inhibits chemokinesis in equine neutrophils
by: Natalia Morales, et al.
Published: (2018-10-01)